These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8750398)
1. Risk of selected serious cardiac events among new users of antihistamines. Staffa JA; Jones JK; Gable CB; Verspeelt JP; Amery WK Clin Ther; 1995; 17(6):1062-77. PubMed ID: 8750398 [TBL] [Abstract][Full Text] [Related]
2. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. de Abajo FJ; Rodríguez LA Br J Clin Pharmacol; 1999 Mar; 47(3):307-13. PubMed ID: 10215756 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [TBL] [Abstract][Full Text] [Related]
6. Use of astemizole in a large group practice. Craig TJ; Greenwald M; Kauffmann V; Craig J J Am Osteopath Assoc; 1996 Jun; 96(6):352-4. PubMed ID: 8690622 [TBL] [Abstract][Full Text] [Related]
7. Safety of antihistamines in children. Ten Eick AP; Blumer JL; Reed MD Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817 [TBL] [Abstract][Full Text] [Related]
8. Drug interactions associated with terfenadine and related nonsedating antihistamines. Zechnich AD; Haxby DG West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212 [No Abstract] [Full Text] [Related]
9. Variations among non-sedating antihistamines: are there real differences? Mattila MJ; Paakkari I Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901 [TBL] [Abstract][Full Text] [Related]
10. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Hanrahan JP; Choo PW; Carlson W; Greineder D; Faich GA; Platt R Ann Epidemiol; 1995 May; 5(3):201-9. PubMed ID: 7606309 [TBL] [Abstract][Full Text] [Related]
11. Antihistamine drug withdrawn by manufacturer. Gottlieb S BMJ; 1999 Jul; 319(7201):7. PubMed ID: 10390435 [No Abstract] [Full Text] [Related]
13. [Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias]. Viramontes-Madrid JL; Jerjes-Sánchez C; Pelaez-Ballestas I; Aguilar-Chiu A; Hernández-Garduño AG Rev Invest Clin; 2002; 54(3):192-7. PubMed ID: 12183887 [TBL] [Abstract][Full Text] [Related]
14. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans? Cavero I; Mestre M; Guillon JM; Heuillet E; Roach AG Drug Saf; 1999; 21 Suppl 1():19-31; discussion 81-7. PubMed ID: 10597865 [TBL] [Abstract][Full Text] [Related]
15. Dangers of non-sedating antihistamines. Clark S Lancet; 1997 May; 349(9061):1268. PubMed ID: 9142059 [No Abstract] [Full Text] [Related]
16. Non sedating antihistamines. Katelaris CH Aust Fam Physician; 1993 Sep; 22(9):1649-53. PubMed ID: 7902082 [TBL] [Abstract][Full Text] [Related]
17. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines. Soter NA J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011 [TBL] [Abstract][Full Text] [Related]
18. QT prolongation on the standard dose of astemizole. Gowardman J N Z Med J; 1996 Feb; 109(1015):38. PubMed ID: 8606815 [No Abstract] [Full Text] [Related]
19. Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe. Poluzzi E; Raschi E; Godman B; Koci A; Moretti U; Kalaba M; Wettermark B; Sturkenboom M; De Ponti F PLoS One; 2015; 10(3):e0119551. PubMed ID: 25785934 [TBL] [Abstract][Full Text] [Related]
20. The current cardiac safety situation with antihistamines. Yap YG; Camm AJ Clin Exp Allergy; 1999 Mar; 29 Suppl 1():15-24. PubMed ID: 10209701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]